Oscar Health (OSCR) CAO awarded 17,300 RSUs and sells shares for taxes

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Oscar Health, Inc. Chief Accounting Officer Victoria Baltrus reported equity compensation and a related share sale. She acquired 17,300 shares of Class A common stock in the form of restricted stock units that will vest quarterly in 12 equal installments beginning on June 1, 2026, subject to her continuous service. She also sold 4,638 shares of Class A common stock at a weighted average price of $13.39 per share, in transactions executed between $13.00 and $13.85, under a Rule 10b5-1 instruction letter to cover tax withholding from previously vested equity awards. After these transactions, she directly owned 216,112 shares.

Insider Trade Summary

Net Seller: 4,638 shares ($62,103)

Net Sell 2 txns

Insider Baltrus Victoria

Role Chief Accounting Officer

Sold 4,638 shs ($62K)

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	17,300	$0.00	--
Sale	Class A Common Stock	4,638	$13.39	$62K

Holdings After Transaction: Class A Common Stock — 220,750 shares (Direct)

Footnotes (1)

The shares represent restricted stock units, which will vest quarterly in 12 equal installments beginning on June 1, 2026, subject to the reporting person's continuous service through each vesting date. Includes shares to be issued in connection with the vesting of one or more restricted stock units. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Form 4 Insider Transactions: What Each Field Means →

03/04/2026 - 04:19 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baltrus Victoria

(Last)

(First)

(Middle)

75 VARICK STREET, 5TH FLOOR

(Street)

NEW YORK

10013

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Oscar Health, Inc. [ OSCR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	03/02/2026		A		17,300⁽¹⁾	A	$0	220,750⁽²⁾	D
Class A Common Stock	03/02/2026		S		4,638⁽³⁾	D	$13.39⁽⁴⁾	216,112	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The shares represent restricted stock units, which will vest quarterly in 12 equal installments beginning on June 1, 2026, subject to the reporting person's continuous service through each vesting date.

2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.

3. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Remarks:

	/s/ Melissa Curtin, Attorney-in-fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Oscar Health (OSCR) report for Victoria Baltrus?

Oscar Health reported that Chief Accounting Officer Victoria Baltrus received 17,300 restricted stock units and sold 4,638 shares of Class A common stock. The sale was executed under a Rule 10b5-1 instruction to satisfy tax withholding obligations from previously vested equity awards.

How many Oscar Health (OSCR) shares did Victoria Baltrus acquire in this Form 4?

Victoria Baltrus acquired 17,300 shares of Oscar Health Class A common stock in the form of restricted stock units. These units vest quarterly in 12 equal installments starting June 1, 2026, and each vesting is conditioned on her continued service with the company.

What are the vesting terms for the new Oscar Health (OSCR) restricted stock units?

The 17,300 restricted stock units granted to Victoria Baltrus vest in 12 equal quarterly installments. Vesting begins on June 1, 2026, and each installment requires her to remain in continuous service through the applicable vesting date, aligning compensation with ongoing employment.

How many Oscar Health (OSCR) shares did Victoria Baltrus sell, and at what price?

Victoria Baltrus sold 4,638 shares of Oscar Health Class A common stock at a weighted average price of $13.39 per share. The transactions occurred in a price range from $13.00 to $13.85, as disclosed in the Form 4 footnotes.

Why did Victoria Baltrus sell Oscar Health (OSCR) shares under a Rule 10b5-1 plan?

The sale of 4,638 Oscar Health shares by Victoria Baltrus was executed under a Rule 10b5-1 instruction letter. According to the filing, the purpose was to satisfy tax withholding obligations arising from the vesting of previously granted equity awards, rather than discretionary selling.

How many Oscar Health (OSCR) shares does Victoria Baltrus own after these transactions?

Following the reported grant and sale, Victoria Baltrus directly owns 216,112 shares of Oscar Health Class A common stock. This figure includes shares to be issued upon the vesting of one or more restricted stock units, as described in the Form 4 footnotes.